麗珠醫藥(01513.HK)腸溶微丸製備方法獲頒專利證書

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

麗珠醫藥(01513.HK)腸溶微丸製備方法獲頒專利證書

阿思達克 05-11 09:31

麗珠醫藥(01513.HK)公布，收到國家知識產權局頒發就腸溶微丸、其製備方法和包含它的製劑的《發明專利證書》，腸溶微丸從內向外依次包括藥丸芯、隔離層和腸溶層，藥丸芯含有艾普拉唑和/或艾普拉唑的藥學上可接受的鹽和第一輔料。公司指出，上述發明專利技術目前已應用於公司艾普拉唑微丸腸溶片研發項目中，公司自主研發的艾普拉唑微丸腸溶片已於去年11月獲批開展臨床試驗。

麗珠醫藥(01513.HK)

Relevant Stocks

麗珠醫藥(01513.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

麗珠醫藥(01513.HK)腸溶微丸製備方法獲頒專利證書

Services

About Us

Agreement Statement